These tables show the significance testing results between a particular state and other states or the national estimate. They are in CSV or Excel format.
SAMHSA Prevention Day, February 4, 2019 Elinore F. McCance-Katz, MD, PhD, Assistant Secretary for Mental Health and Substance Use, Substance Abuse and Mental Health Services Administration, Department of Health and Human Services
View the recorded presentation and webcast...
These are the pill images used in the prescription drug use items within the 2019 NSDUH Questionnaire.
This is the 2019 NSDUH questionnaire used for screening respondents.
These are the 2019 showcards field interviewers use during the interview.
This is the 2019 NSDUH interview questionnaire. The table of contents allows you to jump to particular sections.
2019 Methodological Resource Book
This report evaluates NSDUH\'s coverage of several demographic, socioeconomic, and geographic domains or subpopulations that are of interest to data users. It is intended to be an informative summary of NSDUH coverage with respect to other sources of data. In most cases, the data source that is used for comparison...
This document provides information on the model-based small area estimates of substance use and mental disorders in states based on data from the combined 2016-2017 National Surveys on Drug Use and Health (NSDUHs).
States Categorized into Five Groups from Lowest to Highest Estimate, by Age Group: Percentages, Annual Averages Based on 2016 and 2017 NSDUHs
The 116 national maps presented here show the 2016-2017 National Survey on Drug Use and Health (NSDUH) estimates for 30 substance use and mental health outcomes, by age group, for 50 states
and the District of Columbia.
These tables compare 2008-2009 state-level estimates to 2016-2017 state-level estimates.
These tables compare 2015-2016 state-level estimates to 2016-2017 state-level estimates.
These are the percentage estimates for the 2016-2017 at the state level.
These summary sheets are 2015 and 2016 NSDUH estimates such as binge drinking, illicit drug use, and treatment use for bisexual, lesbian/gay, and sexual minorities.